NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $115,000 | +57.5% | 44,002 | 0.0% | 0.00% | – |
| Q4 2018 | $73,000 | -82.9% | 44,002 | -50.0% | 0.00% | – |
| Q3 2018 | $426,000 | +53.2% | 88,004 | +98.2% | 0.00% | – |
| Q2 2018 | $278,000 | -24.7% | 44,408 | 0.0% | 0.00% | – |
| Q1 2018 | $369,000 | -18.5% | 44,408 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $453,000 | +41.1% | 44,408 | +26.6% | 0.00% | – |
| Q3 2017 | $321,000 | +13.0% | 35,065 | -9.7% | 0.00% | – |
| Q2 2017 | $284,000 | +32.7% | 38,853 | +31.0% | 0.00% | – |
| Q1 2017 | $214,000 | +43.6% | 29,663 | +16.3% | 0.00% | – |
| Q4 2016 | $149,000 | +3.5% | 25,496 | +16.3% | 0.00% | – |
| Q3 2016 | $144,000 | -29.1% | 21,924 | 0.0% | 0.00% | – |
| Q2 2016 | $203,000 | +232.8% | 21,924 | +289.6% | 0.00% | – |
| Q1 2016 | $61,000 | -24.7% | 5,628 | 0.0% | 0.00% | – |
| Q4 2015 | $81,000 | -31.4% | 5,628 | 0.0% | 0.00% | – |
| Q3 2015 | $118,000 | – | 5,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,858,889 | $7,337,000 | 5.11% |
| Proxima Capital Management, LLC | 170,294 | $257,000 | 0.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,530,731 | $5,331,000 | 0.44% |
| Nantahala Capital Management | 4,610,000 | $6,961,000 | 0.21% |
| Wealthstar Advisors, LLC | 73,295 | $111,000 | 0.07% |
| Alambic Investment Management, L.P. | 51,733 | $78,000 | 0.06% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $151,000 | 0.05% |
| BCS Wealth Management | 29,520 | $45,000 | 0.03% |
| Allred Capital Management, LLC | 24,995 | $37,742,000 | 0.02% |
| ALGERT GLOBAL LLC | 34,254 | $52,000 | 0.02% |